相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
Carol Van Hulle et al.
ALZHEIMERS & DEMENTIA (2021)
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
Joana B. Pereira et al.
BRAIN (2021)
Head-to-Head Comparison of 8 Plasma Amyloid-beta 42/40 Assays in Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Blood Biomarkers: Democratizing Alzheimer's Diagnostics
Henrik Zetterberg et al.
NEURON (2020)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2019)
The Clinical Relevance of Methods for Handling Inconclusive Medical Test Results: Quantification of Uncertainty in Medical Decision-Making and Screening
Johannes A. Landsheer
DIAGNOSTICS (2018)
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
Shorena Janelidze et al.
JAMA NEUROLOGY (2017)
Interval of Uncertainty: An Alternative Approach for the Determination of Decision Thresholds, with an Illustrative Application for the Prediction of Prostate Cancer
Johannes A. Landsheer
PLOS ONE (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
Nathalie Le Bastard et al.
CLINICAL CHEMISTRY (2015)
Sources of Variability in Biomarker Concentrations
Lesa L. Aylward et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
A gray zone assigned to inconclusive results of quantitative diagnostic tests: Application to the use of brain natriuretic peptide for diagnosis of heart failure in acute dyspneic patients
Joel Coste et al.
CLINICAL CHEMISTRY (2006)
分享论文
